Quality of life, depression, and anxiety in Turkish children with vitiligo and their parents

Önen, Özlem; Kundak, Selcen; Erkuran, Handan Özek; Kutlu, Ayşe; Çakaloz, Burcu

doi:10.1080/24750573.2018.1454385

Cited by 7 publications

(19 citation statements)

References 65 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For example, depression has been reported to play a role in various stages of inflammation by affecting the number and function of cells in the immune system and by altering the release of proinflammatory cytokines 2 . Physiological factors causing and mediating emotional stress are considered to have a triggering role in the formation or exacerbation of various dermatological diseases 14,15 . In the current study, in parallel with the literature, we found that in the detailed psychiatric evaluation of the patients with vitiligo, 90% of the patients had at least one psychiatric disease according to K‐SADS‐PL.…”

Section: Discussionsupporting

confidence: 80%

Quality of life, emotion dysregulation, attention deficit and psychiatric comorbidity in children and adolescents with vitiligo

Ucuz¹,

Altunışık²,

Şener³

et al. 2020

Clin Exp Dermatol

View full text Add to dashboard Cite

Background. To date there is limited literature on the prevalence of chronic skin conditions and its association with levels of physical activity (PA) in Spain. Aim. To determine the prevalence of chronic skin disease and to compare levels of PA between people with and without chronic skin disease in a large representative sample of Spanish adults aged 15-69 years. Methods. Data from the Spanish National Health Survey 2017 were analysed. Chronic skin disease was assessed using a yes/no question. PA was measured using the short form of the International Physical Activity Questionnaire. Total PA metabolic equivalent of task min/week were calculated, and PA was included in the analyses as a continuous and a five-category variable. Results. This cross-sectional study included 17 777 adult participants (52.0% women; mean AE SD age 45.8 AE 14.1 years), of whom 940 (5.3%) had chronic skin disease. After adjusting for several potential confounders, there was a negative association between chronic skin disease and PA (OR = 0.87, 95% CI 0.76-1.00, P = 0.05), which was significant for men (OR = 0.76, 95% CI 0.62-0.93, P = 0.01) but not for women (OR = 0.97, 95% CI 0.81-1.16, P = 0.72). Conclusions. In this large representative sample of Spanish adults, the prevalence of chronic skin disease was low. Levels of PA were lower in men with than in men without chronic skin conditions, but this association was not seen in women.

show abstract

Section: Discussionsupporting

confidence: 80%

Quality of life, emotion dysregulation, attention deficit and psychiatric comorbidity in children and adolescents with vitiligo

Ucuz¹,

Altunışık²,

Şener³

et al. 2020

Clin Exp Dermatol

View full text Add to dashboard Cite

show abstract

“…Caregiver (e.g., parents, sibling, spouse) burden and associated factors were discussed in ten articles [ 20 , 24 , 53 , 64 , 86 , 103 , 111 , 121 , 139 , 172 ], although only four provided prevalence rates [ 64 , 86 , 103 , 111 ] for aspects of psychosocial burden. Overall QoL among caregivers was impaired, with depression, anxiety, emotional distress, and impaired social life commonly mentioned.…”

Section: Resultsmentioning

confidence: 99%

“…There were no notable consistencies across studies regarding factors affecting caregiver burden. Two studies reported significant parental depression vs controls [ 24 , 121 ], and one study showed that caregiver depression and anxiety significantly reduced QoL among patients with vitiligo [ 111 ].…”

Section: Resultsmentioning

confidence: 99%

Psychosocial Effects of Vitiligo: A Systematic Literature Review

et al. 2021

View full text Add to dashboard Cite

Background Patients with vitiligo experience reduced quality of life. Objective To comprehensively describe the available evidence for psychosocial burden in vitiligo. Methods A systematic review of observational studies and clinical trials identified using PubMed, EMBASE, Scopus, and the Cochrane databases was performed through 1 March, 2021, to assess psychosocial comorbidities in vitiligo. Two independent reviewers performed an assessment of articles and extracted data for qualitative synthesis. Results Included studies (N = 168) were published between 1979 and 1 March, 2021; 72.6% were published since 2010. Disorders including or related to depression (41 studies, 0.1-62.3%) and anxiety (20 studies, 1.9-67.9%) were the most commonly reported. The most prevalent psychosocial comorbidities were feelings of stigmatization (eight studies, 17.3-100%), adjustment disorders (12 studies, 4-93.9%), sleep disturbance (seven studies, 4.6-89.0%), relationship difficulties including sexual dysfunction (ten studies, 2.0-81.8%), and avoidance or restriction behavior (12.5-76%). The prevalence of most psychosocial comorbidities was significantly higher vs healthy individuals. Factors associated with a significantly higher burden included female sex, visible or genital lesions, age < 30 years (particularly adolescents), and greater body surface area involvement, among others. The most commonly reported patient coping strategy was lesion concealment. Limitations Available studies were heterogeneous and often had limited details; additionally, publication bias is possible. Conclusions The results of this systematic review show that vitiligo greatly affects psychosocial well-being. The extent of psychosocial comorbidities supports the use of multidisciplinary treatment strategies and education to address the vitiligoassociated burden of disease. Protocol Registration PROSPERO (CRD42020162223).

show abstract

“…16 In another study, children's level of anxiety and depression symptoms did not significantly differ from the control group. 15 However, Ucuz et al reported that the state and trait anxiety scores of children with vitiligo were different from those of the controls. 17 The awareness that pediatric patients with alopecia areata and vitiligo are closely related to psychological factors is essential and psychiatric evaluation is important in the management of this population.…”

Section: Discussionmentioning

confidence: 99%

Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross‐sectional controlled study

Erdoğan

Gür

Doğan

2020

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Background: Alopecia areata (AA) and vitiligo are associated with various psychiatric comorbidities, and the care of a child with AA or vitiligo may be associated with higher anxiety and depression than healthy children. Aims:We aimed to identify psychiatric findings in children and adolescent groups with AA and vitiligo and to evaluate the levels of anxiety and depression in their parents.Methods: This study included 31 patients with AA and 29 patients with vitiligo, aged seven to 17 years, and their parents. Age-and gender-matched 30 controls and their parents were included. The patients and controls completed the Revised Child Anxiety and Depression Scales-Child version (RCADS-C), and their parents completed the parent version (RCADS-P). The parents also completed the Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI). In addition, the stressful event history of all cases was noted.Results: Stressful event history was higher in the vitiligo group compared to the AA group, and it was higher in the AA and vitiligo groups compared to the control group. Separation anxiety, generalized anxiety, social phobia, and major depressive disorder (MDD) scores were higher in the AA group than controls according to the RCADS-C. According to the RCADS-P, panic disorder (PD), MDD, and total anxiety scores were higher in the AA group. Only the PD and MDD scores were higher in the vitiligo group than those of the controls based on the RCADS-P. Lastly, no significant difference was observed between the three groups concerning the parents' BAI and BDI scores.Conclusions: Stressful events were more common in pediatric patients with vitiligo than those with AA. Anxiety symptoms were more prevalent in patients with AA than those with vitiligo. K E Y W O R D S alopecia, psychological aspects, quality of life, vitiligo | 2233 Savaş ERDOĞaN Et al.How to cite this article: Erdoğan SS, Gür TF, Doğan B. Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross-sectional controlled study. J

show abstract

Quality of life, depression, and anxiety in Turkish children with vitiligo and their parents

Cited by 7 publications

References 65 publications

Quality of life, emotion dysregulation, attention deficit and psychiatric comorbidity in children and adolescents with vitiligo

Quality of life, emotion dysregulation, attention deficit and psychiatric comorbidity in children and adolescents with vitiligo

Psychosocial Effects of Vitiligo: A Systematic Literature Review

Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross‐sectional controlled study

Contact Info

Product

Resources

About